Michel Obeid

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Left Ventricular

Squamous Cell Carcinoma

Interstitial Lung Disease

Myasthenia Gravis

Top Venues

Journal of neurology

Nature communications

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Victor Joo, Karim Abdelhamid, Alessandra Noto, Sofiya Latifyan, Federica Martina, Douglas Daoudlarian, Rita De Micheli, Menno Pruijm, Solange Peters, Roger Hullin, Olivier Gaide, Guiseppe Pantaleo, Michel Obeid
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. Nature communications 15 (1) (2024)
Victor Joo, Karim Abdelhamid, Alessandra Noto, Sofiya Latifyan, Federica Martina, Douglas Daoudlarian, Rita De Micheli, Menno Pruijm, Solange Peters, Roger Hullin, Olivier Gaide, Guiseppe Pantaleo, Michel Obeid
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. Nature communications 15 (1) (2024)
Victor Joo, Karim Abdelhamid, Alessandra Noto, Sofiya Latifyan, Federica Martina, Douglas Daoudlarian, Rita De Micheli, Menno Pruijm, Solange Peters, Roger Hullin, Olivier Gaide, Guiseppe Pantaleo, Michel Obeid
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. Nature communications 15 (1) (2024)
Victor Joo, Karim Abdelhamid, Alessandra Noto, Sofiya Latifyan, Federica Martina, Douglas Daoudlarian, Rita De Micheli, Menno Pruijm, Solange Peters, Roger Hullin, Olivier Gaide, Guiseppe Pantaleo, Michel Obeid
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. Nature communications 15 (1) (2024)
Victor Joo, Karim Abdelhamid, Alessandra Noto, Sofiya Latifyan, Federica Martina, Douglas Daoudlarian, Rita De Micheli, Menno Pruijm, Solange Peters, Roger Hullin, Olivier Gaide, Guiseppe Pantaleo, Michel Obeid
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. Nature communications 15 (1) (2024)
Raffaella Brugnoni, Andreas F Hottinger, Sofiya Latifyan, Sarah Boughdad, Fabio Becce, John O Prior, Thierry Kuntzer, Jean-Philippe Brouland, Vincent Dunet, Michel Obeid, Marie Théaudin
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series. Journal of neurology 271 (4) (2023)
Rita Godinho, Alessandra Noto, Craig Fenwick, Athina Stravodimou, Sarah Hugelshofer, Solange Peters, Roger Hullin, Michel Obeid
Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapies. Journal for immunotherapy of cancer 11 (6) (2023)
Raffaella Brugnoni, Andreas F Hottinger, Sofiya Latifyan, Sarah Boughdad, Fabio Becce, John O Prior, Thierry Kuntzer, Jean-Philippe Brouland, Vincent Dunet, Michel Obeid, Marie Théaudin
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series. Journal of neurology 271 (4) (2023)
Rita Godinho, Alessandra Noto, Craig Fenwick, Athina Stravodimou, Sarah Hugelshofer, Solange Peters, Roger Hullin, Michel Obeid
Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapies. Journal for immunotherapy of cancer 11 (6) (2023)
Raffaella Brugnoni, Andreas F Hottinger, Sofiya Latifyan, Sarah Boughdad, Fabio Becce, John O Prior, Thierry Kuntzer, Jean-Philippe Brouland, Vincent Dunet, Michel Obeid, Marie Théaudin
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series. Journal of neurology 271 (4) (2023)
Raffaella Brugnoni, Andreas F Hottinger, Sofiya Latifyan, Sarah Boughdad, Fabio Becce, John O Prior, Thierry Kuntzer, Jean-Philippe Brouland, Vincent Dunet, Michel Obeid, Marie Théaudin
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series. Journal of neurology (2023)
Raffaella Brugnoni, Andreas F Hottinger, Sofiya Latifyan, Sarah Boughdad, Fabio Becce, John O Prior, Thierry Kuntzer, Jean-Philippe Brouland, Vincent Dunet, Michel Obeid, Marie Théaudin
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series. Journal of neurology 271 (4) (2023)
Raffaella Brugnoni, Andreas F Hottinger, Sofiya Latifyan, Sarah Boughdad, Fabio Becce, John O Prior, Thierry Kuntzer, Jean-Philippe Brouland, Vincent Dunet, Michel Obeid, Marie Théaudin
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series. Journal of neurology 271 (4) (2023)
Sarah Boughdad, Sofiya Latifyan, Craig Fenwick, Hasna Bouchaab, Madeleine Suffiotti, Javid J Moslehi, Joe-Elie Salem, Niklaus Schaefer, Marie Nicod Lalonde, Julien Costes, Matthieu Perreau, Olivier Michielin, Solange Peters, John O Prior, Michel Obeid
68 Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis. Journal for immunotherapy of cancer 9 (10) (2022)
Fangwen Zou, David Faleck, Anusha Thomas, Jessica Harris, Deepika Satish, Xuemei Wang, Aline Charabaty, Marc S Ernstoff, Isabella C Glitza Oliva, Stephen Hanauer, Jennifer McQuade, Michel Obeid, Amishi Shah, David M Richards, Elad Sharon, Jedd Wolchok, John Thompson, Yinghong Wang
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study. Journal for immunotherapy of cancer 9 (11) (2022)
Alexander Coukos, Julien Vionnet, Michel Obeid, Hasna Bouchaab, Solange Peters, Sofiya Latifyan, Alexandre Wicky, Olivier Michielin, Haithem Chtioui, Darius Moradpour, François Fasquelle, Christine Sempoux, Montserrat Fraga
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events. Journal for immunotherapy of cancer 10 (10) (2022)